Share information

Basic information

The Company’s share is listed on the First North Growth Market Finland marketplace.

Trading symbol First North Growth Market Finland: BONEH

ISIN-code: FI4000260583

Industry: Health care
Number of Shares: 20,747,175. The Company holds 276,838 treasury shares (Updated on July 22, 2024).

The subscription period for the Initial Public Offering was: 5.2.2018 – 18.2.2018
LEI-ID: 743700BYSBP0PCR6N767
Company ID: 0866451-4
VAT-number: FI08664514

The company’s shares are attached to the book-entry securities system maintained by Euroclear Finland and in Euroclear Sweden.  The shareholder register of the BBS is maintained, and the owner list of shareholders is available at Euroclear Finland Oy at Urho Kekkosen katu 5 C, 8. floor, Helsinki

Major shareholders

Updated on July 2, 2024

Owner
Number of shares
% of outstanding share
1 Municipality of Reisjärvi 2,677,716 12.91%
2 Finha Capital Oy 2,357,965 11.37%
3 Panvest Oy 1,304,590 6.29%
4 Jalovaara, Pekka 654,050 3.15%
5 Paananen, Ahti 520,904 2.51%
6 Halonen, Jukka 280,580 1.35%
7 Halonen, Veronika 254,369 1.23%
8 Rosenqvist, Alexandra 253,971 1.22%
9 Celltronix Oy 232,500 1.12%
10 Nordnet Bank AB, nominee registered  224,072 1.08%
10 largest
8,760,717 42.23%
Others 11,986,458 57.77%
Total 20,747,175 100%
BBS-Bioactive Bone Substitutes Oyj 276,838 1.33%

 

Certified advisors

BBS’s shares are traded on the First North Growth Market Finland marketplace held by NASDAQ Helsinki Ltd, where the appointment of certified advisor (CA) is required. Approved certified advisors will ensure that the company meets the marketplace requirements and obligations.

 

Certified Advisor is:

Nordic Certified Adviser AB
Stureplan 15
SE-111 45 Stockholm
Sweden
+46 70 551 67 29
info@certifiedadviser.se

 

Analysts

According to our knowledge the following analysts have regular coverage on BBS. The company is not responsible for their views.

Inderes

Antti Siltanen
+358 45 119 6869
antti.siltanen@inderes.fi
https://www.inderes.fi/fi/yhtiot/bbs